Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

SP 0202

Next Previous
Drug Profile

SP 0202

Alternative Names: GBP-410; Next Gen PCV - Sanofi; Next-generation pneumococcal conjugate vaccine - Sanofi/SK Bioscience; PCV21; Pneumococcal vaccine conjugate - Sanofi Pasteur/SK Bioscience; SP-0202; SP0202-IIb; SP0202-VI; SP0202-VII

Latest Information Update: 06 Jun 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator sanofi pasteur; SK Chemicals
  • Developer Sanofi; Sanofi Pasteur; SK Bioscience; SK Chemicals
  • Class Conjugate vaccines; Pneumococcal vaccines; Polysaccharides
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase III Pneumococcal infections

Most Recent Events

  • 22 May 2025 Phase-III clinical trials in Pneumococcal infections (Prevention, In infants) in Poland (IM) (NCT06975878)
  • 21 May 2025 Sanofi plans a phase III trial for Pneumococcal infections (In children, In infants, Prevention) (IM) (NCT06975878)
  • 27 Feb 2025 Sanofi initiates a phase-III clinical trial in Pneumococcal infections (In infants, Prevention) (IM) (NCT06824181)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top